Albert Lowe
Stock Analyst at Craig-Hallum
(0.86)
# 3,708
Out of 4,761 analysts
5
Total ratings
20%
Success rate
-4.01%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Albert Lowe
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SABS SAB Biotherapeutics | Initiates: Buy | $11 | $1.82 | +504.40% | 1 | Oct 9, 2024 | |
| CRDF Cardiff Oncology | Initiates: Buy | $8 | $4.75 | +68.42% | 1 | Sep 6, 2024 | |
| LCTX Lineage Cell Therapeutics | Initiates: Buy | $4 | $0.68 | +491.72% | 1 | Aug 20, 2024 | |
| SKYE Skye Bioscience | Initiates: Buy | $18 | $2.98 | +504.03% | 1 | Jul 9, 2024 | |
| PMVP PMV Pharmaceuticals | Initiates: Buy | $6 | $1.41 | +325.53% | 1 | May 13, 2024 |
SAB Biotherapeutics
Oct 9, 2024
Initiates: Buy
Price Target: $11
Current: $1.82
Upside: +504.40%
Cardiff Oncology
Sep 6, 2024
Initiates: Buy
Price Target: $8
Current: $4.75
Upside: +68.42%
Lineage Cell Therapeutics
Aug 20, 2024
Initiates: Buy
Price Target: $4
Current: $0.68
Upside: +491.72%
Skye Bioscience
Jul 9, 2024
Initiates: Buy
Price Target: $18
Current: $2.98
Upside: +504.03%
PMV Pharmaceuticals
May 13, 2024
Initiates: Buy
Price Target: $6
Current: $1.41
Upside: +325.53%